Yasar, Carene D.
HRN: 13-99-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2022
CEFUROXIME 1.5GM (VIAL)
11/25/2022
11/27/2022
IVT
1.5gms
Q8Hx 4 Doses
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes